B7RP-1 Antibodies

Santa Cruz Biotechnology offers a broad range of B7RP-1 monoclonal antibodies for immunology and cell biology research. B7RP-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). B7RP-1, also known as PD-1 ligand 2, plays a crucial role in regulating immune responses by modulating T-cell activation and tolerance. The interaction between B7RP-1 and PD-1 significantly impacts immune checkpoint regulation, making B7RP-1 a key target for therapeutic interventions in cancer and autoimmune diseases. Understanding B7RP-1 function advances research in immune modulation and supports the development of novel treatment strategies. Researchers can explore B7RP-1's role in various cellular pathways and mechanisms using specific detection methods. Investigating B7RP-1 expression patterns helps reveal its involvement in different physiological and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for B7RP-1 enable researchers worldwide to advance scientific understanding of immune system regulation and potential therapeutic applications.